Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. uri icon

authors

  • Matthews, Andrew H
  • Frey, Noelle V
  • Hexner, Elizabeth O
  • Martin, Mary Ellen
  • Shannon R. McCurdy, MD
  • Stadtmauer, Edward A
  • Paralkar, Vikram R
  • Bruno, Ximena Jordan
  • Hwang, Wei-Ting
  • Margolis, David
  • Pratz, Keith W
  • Perl, Alexander E
  • Luger, Selina M
  • Loren, Alison W
  • Gill, Saar I
  • Porter, David L
  • Babushok, Daria V
  • Maillard, Ivan P
  • Carroll, Martin P

publication date

  • July 12, 2022